Your session is about to expire
← Back to Search
Rituximab + Chemotherapy +/- Lenalidomide for Lymphoma
Study Summary
This trial is testing rituximab and combination chemotherapy with or without lenalidomide to treat patients with newly diagnosed stage II-IV diffuse large B cell lymphoma to see if it is more effective with or without lenalidomide.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a condition where my lymphocytes grow abnormally.I have a history of cancer.I have a tumor tissue sample from my initial biopsy ready for analysis.I am willing and able to take blood thinning medication as prescribed.I do not have AIDS or conditions related to it, and if HIV positive, I am on certain antiretrovirals with a CD4 count over 400.I have no active cancer needing treatment, except for possibly treated skin cancer or another cancer considered cured.I haven't had cancer in the last 5 years, except for skin cancer.My cancer is at an advanced stage or has a large tumor over 10 cm.I am not taking any medications to increase my red blood cells.I have DLBCL with CD20, no transformed or primary mediastinal type, and c-myc status doesn't exclude me.I am able to get out of my bed or chair and move around.I have lymphoma and haven't started any treatment yet, but I may have taken steroids for symptoms.I don't have cancer in my brain or spinal cord.I don't have a history of serious blood clots, or I'm willing to take strong blood thinners if needed.I haven't had a heart attack in the last 6 months or heart failure needing constant treatment.I haven't had radiation on a large part of my bone marrow or anthracycline therapy.
- Group 1: Arm A (rituximab, combination chemotherapy, lenalidomide)
- Group 2: Arm B (rituximab, combination chemotherapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many health care facilities in the United States are involved with this research endeavor?
"Currently, this medical study is accepting participants at 100 clinics across the US. Fort Sam Houston, Mishawaka and Las Vegas are locations that offer recruitment services for this trial; however, there are many additional sites available to decrease travel burden."
What medical conditions have lenalidomide been known to address?
"Lenalidomide has demonstrated effectiveness in treating pheochromocytomas, ulcerative colitis, and cases of varicella-zoster virus induced acute retinal necrosis."
Are there any openings for participation in this experiment?
"At this time, the trial is not accepting additional patients. It was initially posted on August 27th 2013 and most recently revised on September 23rd 2022. Currently, 1766 medical studies are actively recruiting participants with lymphoma/B-cell while 1682 trials involving lenalidomide have open enrolment opportunities."
Has the Federal Drug Administration certified Lenalidomide for medical use?
"Lenalidomide has some evidence for safety, so it was allocated a score of 2. As this is only Phase 2 data however, no proof exists to validate its efficacy."
Are there any other previous investigations that focus on Lenalidomide?
"Currently, there are 1682 Lenalidomide trials that have been activated, with 371 of these within Phase 3. Across the globe, 63640 sites are collect data from and administering treatment for this drug. The majority of studies occur in Joliet, Illinois."
How many individuals are eligible to participate in this trial?
"At the moment, enrollment for this clinical trial is no longer available. The study was initially posted on August 27th 2013 and last updated on September 23rd 2022; however, if you are looking to participate in a similar investigation regarding lymphoma or Lenalidomide there are 1,766 and 1,682 respective trials recruiting patients right now."
Share this study with friends
Copy Link
Messenger